Vaccination of myeloma patients with monoclonal immunoglobulin loaded dendritic cells:: preclinical and first clinical results of a phase I/II clinical trial

被引：0
|
作者：
Ocadlikova, D.
Zahradova, L.
Kovarova, L.
Smejkalova, J.
Pour, L.
Vidlakova, P.
Kyjovska, D.
Stejskalova, A.
Novotna, H.
Penka, M.
Michalek, J.
Hajek, R.
机构：
[1] Masaryk Univ, Cell Immunotherapy Ctr, Brno, Czech Republic
[2] Univ Hosp, Dept Hematooncol, Brno, Czech Republic
[3] Univ Hosp, Dept Pediat 1, Brno, Czech Republic
[4] Univ Hosp, Dept Clin Hematol, Brno, Czech Republic
[5] Univ Hosp, Dept Clin Biochem, Brno, Czech Republic
来源：
BLOOD REVIEWS | 2007年 / 21卷
关键词：
D O I：
10.1016/S0268-960X(07)70213-8
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：S129 / S129
页数：1
相关论文
共 50 条
  • [31] Therapeutic vaccination against advanced pancreatic cancer by autologous dendritic cells pulsed with a MUC1 peptide: Preclinical results of a clinical phase I trial
    Jin, D.
    Rong, Y.
    Lou, W.
    Qin, X.
    Wu, W.
    Nin, X.
    Nin, X.
    Wang, D.
    Kuang, T.
    Qin, Y.
    JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (15)
  • [32] Dendritic cell-based vaccination in metastatic melanoma patients: Phase II clinical trial
    Oshita, Chie
    Takikawa, Masako
    Kume, Akiko
    Miyata, Haruo
    Ashizawa, Tadashi
    Iizuka, Akira
    Kiyohara, Yoshio
    Yoshikawa, Shusuke
    Tanosaki, Ryuji
    Yamazaki, Naoya
    Yamamoto, Akifumi
    Takesako, Kazutoh
    Yamaguchi, Ken
    Akiyama, Yasuto
    ONCOLOGY REPORTS, 2012, 28 (04) : 1131 - 1138
  • [33] Mucin gene (MUC1) transfected dendritic cells as vaccine:: results of a phase I/II clinical trial
    Pecher, G
    Häring, A
    Kaiser, L
    Thiel, E
    CANCER IMMUNOLOGY IMMUNOTHERAPY, 2002, 51 (11-12) : 669 - 673
  • [34] Mucin gene (MUC1) transfected dendritic cells as vaccine: results of a phase I/II clinical trial
    Gabriele Pecher
    Arnt Häring
    Lothar Kaiser
    Eckhard Thiel
    Cancer Immunology, Immunotherapy, 2002, 51 : 669 - 673
  • [35] DENDRITIC CELL VACCINATION AS POST-REMISSION THERAPY FOR ACUTE MYELOID LEUKEMIA: RESULTS OF A PILOT PHASE I/II CLINICAL TRIAL
    Anguille, S.
    Van Tendeloo, V.
    Van de Velde, A.
    Van Driessche, A.
    Vermeulen, K.
    Pieters, K.
    Nijs, G.
    Stein, B.
    Smits, E.
    Schroyens, W.
    Gadisseur, A.
    Vrelust, I.
    Jorens, P.
    Goossens, H.
    Price, D.
    De Vries, J.
    Oji, Y.
    Oka, Y.
    Sugiyama, H.
    Cools, N.
    Berneman, Z.
    EXPERIMENTAL HEMATOLOGY, 2010, 38 (09) : S36 - S37
  • [36] A phase I/II clinical trial evaluating RNA-loaded dendritic cells targeting human cytomegalovirus in patients with newly-diagnosed GBM
    Sampson, John H.
    Mitchell, Duane A.
    Archer, Gary E.
    McGehee-Norman, Sharon
    Perry, Beth A.
    Lally-Goss, Denise
    Schinittling, Robert
    Bigner, Darell D.
    Friedman, Allan H.
    Friedman, Henry S.
    Reardon, David A.
    JOURNAL OF NEUROSURGERY, 2008, 108 (04) : A849 - A850
  • [37] Vaccination with IL-12 gene-modified autologous melanoma cells: preclinical results and a first clinical phase I study
    Sun, Y
    Jurgovsky, K
    Moller, P
    Alijagic, S
    Dorbic, T
    Georgieva, J
    Wittig, B
    Schadendorf, D
    GENE THERAPY, 1998, 5 (04) : 481 - 490
  • [38] Vaccination with IL-12 gene-modified autologous melanoma cells: preclinical results and a first clinical phase I study
    Y Sun
    K Jurgovsky
    P Möller
    S Alijagic
    T Dorbic
    J Georgieva
    B Wittig
    D Schadendorf
    Gene Therapy, 1998, 5 : 481 - 490
  • [39] Next-Generation Dendritic Cell Vaccination in Postremission Therapy of AML: Results of a Clinical Phase I Trial
    Deiser, Katrin
    Lichtenegger, Felix S.
    Schnorfeil, Frauke
    Koehnke, Thomas
    Altmann, Torben
    Buecklein, Veit
    Moosmann, Andreas
    Brueggemann, Monika
    Wagner, Beate
    Hiddemann, Wolfgang
    Bigalke, Iris
    Kvalheim, Gunnar
    Subklewe, Marion S.
    BLOOD, 2015, 126 (23)
  • [40] Next-generation dendritic cell vaccination in postremission therapy of AML: results of a clinical phase I trial
    Lichteneager, F. S.
    Schnorfeil, F. M.
    Brueggemann, M.
    Moosmann, A.
    Koehnke, T.
    Buecklein, V.
    Altmann, T.
    Wagner, B.
    Hiddemann, W.
    Bigalke, I
    Kvalheim, G.
    Subklewe, M.
    Oncology Research and Treatment, 2015, 38 : 37 - 37
12345